SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point after its recent earnings report, which, despite showing subscriber growth and exceeding revenue expectations, led to a notable sell-off. Community discussion is split between those viewing the price dip as an overreaction and a long-term buying opportunity, and those concerned about the cautious forward guidance, valuation, and the strategic implications of the potential Warner Bros. Discovery acquisition.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as reports indicate the U.S. government is establishing a new digital asset reserve to hold seized Bitcoin, shifting from prior selling policies and removing market pressure. This comes amidst heightened market volatility, which many in the community attribute to political rhetoric and broader macroeconomic concerns. Investor sentiment remains sharply divided, with intense debate around Bitcoin's role as a digital safe haven compared to traditional assets like gold and silver, while closely watching key technical support levels.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending significantly after Chairman Ryan Cohen increased his stake by purchasing an additional 500,000 shares, which the community views as a powerful signal of confidence. This insider move has ignited fervent speculation about upcoming strategic developments, further reinforced by the stock's notable resilience and positive performance even on days when the broader market is declining.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending sharply lower as markets react to escalating geopolitical tensions over Greenland, which has spurred fear of broad tariffs and an unwind of international capital flows. This immediate catalyst has triggered widespread community debate, fueling predictions of a deeper market correction while others view the pullback as a significant buying opportunity. Discussions are intensely focused on whether current global political rhetoric will continue to drive significant market volatility or if a swift rebound is imminent.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending lower as market sentiment reacts sharply to former President Trump's threats of new tariffs against European allies concerning Greenland. This has ignited a lively debate within the community, with some anticipating a deeper market correction amid broader bond market jitters, while others expect a "buy the dip" rebound, confident in the underlying strength of the tech sector despite geopolitical noise.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN Limited is seeing significant investor attention driven by its strategic pivot from Bitcoin mining to becoming a leading AI cloud infrastructure provider. The company's substantial power capacity and recent $9.7 billion Microsoft GPU cloud contract position it as a critical player in meeting the surging demand for AI compute. Community chatter highlights optimism for further hyperscaler partnerships and long-term growth, with many viewing IREN as undervalued despite market fluctuations.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Holdings Inc

Ondas Holdings is trending following a recent investor day that revealed significantly raised revenue targets and a substantial increase in backlog, prompting multiple analyst upgrades with considerably higher price targets. The community is buzzing about Ondas's strategic pivot to autonomous defense infrastructure, with many asserting the market has yet to fully price in its combat-proven technology and robust financial position. Investors are closely monitoring the integration of acquired assets and potential for major contract announcements in the rapidly evolving drone and counter-drone sectors.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is actively trending following its announced proposed public offering of common stock and warrants, which comes on the heels of an earlier surge driven by positive Phase 1 clinical trial data for its atopic dermatitis drug. The community is sharply divided, with many debating potential dilution and a subsequent price correction, while others view the offering as a strategic capital raise to advance a promising pipeline in a large market. This highlights the inherent tension for clinical-stage biotechs, balancing funding needs with encouraging early-stage therapeutic developments.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The SPDR Dow Jones Industrial Average ETF ($DIA) is trending amidst heightened market uncertainty driven by recent tariff threats related to international trade and escalating geopolitical tensions. Community discussions are focused on the potential for increased volatility and the broader implications of global instability on established market leaders, with some anticipating significant market corrections while others look for buying opportunities.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg Commerce is trending as significant insider share accumulation has reportedly locked up much of its free float, coinciding with rising demand for PC components and AI hardware. The community is intensely discussing perceived aggressive short-seller tactics and "phantom shares" that appear to be suppressing the price on remarkably low volume. This situation is fueling strong investor convictions who anticipate an eventual, explosive short squeeze.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Last month, INVO Fertility signed a definitive agreement to acquire Family Beginnings, a fertility clinic.</li><li>INVO Fertility also announced a private placement worth $4 million last month.</li><li>Terah Krigsvold recently took over as IVF’s chief financial officer, replacing Andrea Goren.</li></ul>INVO Fertility, Inc. (IVF) shares drew significant retail interest on Tuesday, with the stock soaring 350% in premarket trading.Retail watchers for <a href="https://stocktwits.com/symbol/INVO">IVF stock</a> increased a whopping 726% over the last 24 hours and 3,700% over seven days, according to Stocktwits data. Retail sentiment on Stocktwits was ‘extremely bullish’ over the past 24 hours, accompanied by ‘extremely high’ message volumes.<img src="https://news.stocktwits-cdn.com/INVO_jpg_f619340f95.webp" alt="INVO.jpg">A few users speculated on U.S. President Donald Trump cutting costs for fertility treatments.<stembedurl>https://stocktwits.com/DekmarTrades/message/642263565</stembedurl>While others saw a classic pump-and-dump scheme.<stembedurl>https://stocktwits.com/Bonanza2252003/message/642265944</stembedurl>The speculation stems from an October 2025 report on Trump and Merck’s agreeing to reduce the cost of drugs used in in vitro fertilization. Merck’s U.S. unit, EMD Serono, will sell key fertility treatments directly to patients, offering up to an 84% discount when the drugs are used together.<h2 class="st-heading-2">Why Has Retail Been Tracking IVF?</h2>Last month, INVO Fertility signed a definitive agreement to acquire Family Beginnings, P.C., a fertility clinic serving Indiana and the broader Midwest. The deal allows INVO to strategize to expand its network of fertility care centers across the United States.INVO will acquire the non-clinical assets for $750,000, consisting of $350,000 in cash at closing, net of a $150,000 holdback, and $400,000 in Series D non-voting convertible preferred stock. Family Beginnings generated approximately $1.2 million in revenue and $0.2 million in net income over the past year.Prior to that, INVO Fertility announced a private placement with a single institutional investor to sell 2.37 million shares, or pre-funded warrants, along with warrants for up to 4.73 million additional shares, at an effective price of $1.69 per share. The offering generated around $4 million in gross proceeds.Recently, Terah Krigsvold, who has served as INVO’s controller since December 2020, was appointed the Company’s CFO, replacing Andrea Goren. INVO Fertility also implemented a one-for-eight reverse stock split on Nov. 28, 2025.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-ibrx-stock-surging-premarket-fda-anktiva-resubmission/cmUujB3R4aL">IBRX Stock Extends Rally On FDA Feedback For ANKTIVA Bladder Cancer Filing</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

INVO Fertility’s 350% Spike Puts Microcap IVF Stocks Back On Retail Radar

Retail watchers for IVF stock increased a whopping 726% over the last 24 hours and 3,700% over seven days, according to Stocktwits data.

A Little-Known Fertility Stock Soared 350% — Here’s What Traders Are Watching

Equity

<ul class="summary-bullets"><li>ODD is granted to a drug or biological product intended to prevent, diagnose, or treat a rare disease or condition.</li><li>The designation provides Atossa with incentives such as tax credits for qualified clinical trial expenses, exemptions from certain FDA user fees, and potential for seven years of market exclusivity.</li><li>(Z)-Endoxifen is a targeted therapy developed to disrupt estrogen signaling by inhibiting and degrading estrogen receptors.</li></ul>Shares of Atossa Therapeutics (ATOS) rose 10% in premarket trading on Friday, after the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to its investigational therapy (Z)-Endoxifen for Duchenne Muscular Dystrophy.<h2 class="st-heading-2">Importance Of ODD Approval</h2>The FDA can grant ODD to a drug or biological product intended to prevent, diagnose, or treat a rare disease or condition.The designation provides sponsors (Atossa) with several incentives, including tax credits for qualified clinical trial expenses, exemptions from certain FDA user fees, and the potential for seven years of market exclusivity following approval. ODD is a separate process from seeking approval or licensing.Last week, the FDA issued a “Study May Proceed” letter for the company’s metastatic breast cancer trial under an IND for (Z)-endoxifen, a decision the company said supports expanding the drug’s use in ER+/HER2- metastatic breast cancer.<h2 class="st-heading-2">What Is This Investigational Drug?</h2>(Z)-Endoxifen is a selective estrogen receptor modulator designed to inhibit and degrade estrogen receptors, including hormone-resistant cancers. The company is also exploring the drug’s broader therapeutic potential across additional disease pathways. The pharmaceutical company is developing an oral formulation designed to pass through the stomach unchanged, so it doesn’t become inactive.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment for <a href="https://stocktwits.com/symbol/ATOS">ATOS</a> on Stocktwits remained in the ‘bearish’ territory over the past 24 hours, despite the sharp premarket climb.<img src="https://news.stocktwits-cdn.com/ATOS_jpg_2ffe3fc376.webp" alt="ATOS.jpg">One user believes that the news could push the stock price above $1. It is currently at $0.6.<stembedurl>https://stocktwits.com/virviru/message/642015533</stembedurl>Atossa will hold a shareholder meeting on January 20 to propose, among other items, a reverse split of its common stock at a ratio of 5:1 to 20:1.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/nasdaq-sp500-futures-higher-mu-nvda-ntla-asts-msft-stocks-to-watch/cmUlVD2R4Jz">Nasdaq, S&amp;P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

 In this photo illustration, the Atossa Therapeutics logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Did ATOS Stock Jump 10% In Pre-Market Today?

The U.S. Food and Drug Administration granted Orphan Drug Designation to its (Z)-Endoxifen therapy for DMD.

<ul class="summary-bullets"><li>Strive’s stock rose 2.2% after hours following a dip of over 11% in the regular session.</li><li>Semler’s stock gained 1.5% in overnight trading after a fall of nearly 10% in regular hours.</li><li>The gains followed a rally in Bitcoin’s (BTC) price to over $96,000.&nbsp;</li></ul>Shares of Vivek Ramaswamy-backed Strive (ASST) and its merger partner Semler Scientific (SMLR) recovered in overnight trade on Wednesday after an abrupt reverse stock split announcement rattled investors and sent both stocks tumbling during regular market hours.<a href="https://stocktwits.com/symbol/ASST">ASST’s stock</a> rose 2.2% in after-hours trading after a drop of over 11% in regular hours. Retail sentiment around the company remained in ‘extremely bullish’ territory despite the volatility, and retail chatter increased to ‘extremely high’ from ‘high’ levels over the past day. Platform data showed there was a 200% jump in message volume during that time.Meanwhile,&nbsp;<a href="https://stocktwits.com/symbol/SMLR/">SMLR’s stock</a> rose 1.5% in after-hours trade after a drop of nearly 10% in the regular session. It also saw retail sentiment trending in ‘extremely bullish’ territory, accompanied by ‘extremely high’ levels of chatter.The gains followed a rally in&nbsp;<a href="https://stocktwits.com/coins/bitcoin">Bitcoin’s (BTC) price</a> to over $96,000. The cryptocurrency was trading at around $95,400 at the time of writing.<h2 class="st-heading-2">Surprise Reverse Stock Split</h2>Strive shareholders approved the acquisition of Semler Scientific on Tuesday, but investors were not expecting the 1-to-20 reverse stock split announced alongside the deal.Strive’s chief investment officer (CIO) Ben Werkman said the reverse split is intended to "align share price with institutional participation standards" and to increase access for more investors. The stock has mostly traded below $1 since October. A reverse stock split is usually done to avoid delisting and buy time for a turnaround.The merger between the two companies is an all-stock transaction with Strive acquiring more than 5,000 of Semler’s Bitcoin. On completion of the Semler acquisition, the company will hold nearly 12,800 Bitcoin, which would put it ahead of Tesla (TSLA) and Trump Media &amp; Technology Group (DJT) in terms of corporate Bitcoin reserves.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/gpus-sbet-lead-crypto-stocks-rally-following-bitcoin-surge-to-96000/cmULT5xR4IH">GPUS, SBET Lead Crypto Stocks Rally Following Bitcoin’s Surge To $96,000</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Vivek Ramaswamy looks on from the sideline during warmups before the game between the Ohio State Buckeyes and the Penn State Nittany Lions at Ohio Stadium on November 01, 2025 in Columbus, Ohio. (Photo by Jason Mowry/Getty Images)

Vivek Ramaswamy-Backed Strive And Semler Stocks Rebound On Bitcoin Recovery After Reverse Split Shock

An unanticipated 1-for-20 reverse stock split announcement drove investor volatility following merger approval.

Cryptocurrency

<ul class="summary-bullets"><li>Travere said its responses are currently under agency review.</li><li>FDA’s PDUFA target action date for full approval of Filspari in Focal Segmental Glomerulosclerosis is January 13.</li><li>The company expects U.S. net product sales of about $127 million in Q4 and about $410 million for the full year 2025.</li></ul>Shares of Travere Therapeutics Inc.&nbsp;(TVTX) slumped 30% in premarket trading on Tuesday after the company said the U.S. Food and Drug Administration (FDA) requested additional information to assess Filspari’s clinical benefit.Travere said its responses are currently under agency review. Filspari is a treatment for adults with primary immunoglobulin A nephropathy, a progressive kidney disease that can ultimately lead to kidney failure.FDA’s PDUFA (Prescription Drug User Fee Act) target action date for full approval of Filspari in Focal Segmental Glomerulosclerosis (FSGS) is January 13. A PDUFA date is the FDA's target date to make a decision on a drug application. If approved, Filspari would be the first treatment for FSGS, and the company says it is well-positioned for a commercial launch.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the sharp premarket decline, retail sentiment on Stocktwits changed to ‘extremely bullish’ from ‘bullish’ a day back, accompanied by ‘extremely high’ message volumes. <a href="https://stocktwits.com/symbol/TVTX">TVTX</a> was among the top trending tickers on the platform at the time of writing.<img src="https://news.stocktwits-cdn.com/TVTX_jpg_74da780cfd.webp" alt="TVTX.jpg">One user said that the FDA’s request is ‘very common’.<stembedurl>https://stocktwits.com/BIOTECH_GURU/message/641602359</stembedurl>However, one bearish user was skeptical about the timelines.<stembedurl>https://stocktwits.com/Aawilliam2003/message/641609384</stembedurl><h2 class="st-heading-2">2026 Outlook</h2>Travere Therapeutics provided an update on its sales outlook for the fourth quarter and full year 2025. The company expects U.S. net product sales of about $127 million in the fourth quarter (Q4) and about $410 million for the full year, based on preliminary and unaudited results. Travere ended 2025 with around $323 million in cash, cash equivalents, and marketable securities.Clinically, the company plans to advance clinical evidence supporting FILSPARI as a foundational treatment for IgA nephropathy, also known as Berger's disease, a chronic kidney ailment. Its partner, Chugai Pharmaceutical, is expected to submit a New Drug Application (NDA) for Sparsentan in Japan next year.Meanwhile, the company is on track to restart Phase 3 HARMONY Study of Pegtibatinase in classical homocystinuria (HCU), a genetic metabolic disorder, in the first quarter of 2026 following manufacturing process improvements.The stock has seen significant buying interest over the past year, gaining nearly 90%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-nvts-stock-gaining-retail-attention-ai-power-play/cmUXcZPR44k">NVTS Stock Draws Retail Interest On AI Data Center Power Play</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Travere Therapeutics logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Did TVTX Stock Crash 30% In Pre-Market Today?

Shares of Travere Therapeutics Inc. (TVTX) slumped 30% in premarket trading on Tuesday after the company said the U.S. Food and Drug Administration (FDA) requested additional information to assess Filspari’s clinical benefit.

The U.S. Food and Drug Administration recently requested additional information to assess Filspari’s clinical benefit.

<ul class="summary-bullets"><li>The order would also strengthen the company’s position to compete for, and win, larger production opportunities with the army, OSS said.&nbsp;</li><li>In December 2025, OSSwon a $1.2 million production order from Safran Federal Systems.</li><li>In its latest quarterly update, One Stop Systems posted revenues of $18.76, up about 37% from the same period last year.</li></ul>Shares of One Stop Systems Inc. (OSS) have rallied over 50% in the last five days, gaining nearly 30% on Monday. Despite the steep surge, retail investors continue to remain ‘extremely bullish’ on the stock’s performance.Retail optimism comes amid the company’s approximately $1.2 million pre-production order from a U.S. defense prime contractor announced last week. Some investors are touting the potential of multi-year contracts up to $200 million in the U.S. defense and other commercial sectors based on past contracts.<h2 class="st-heading-2">Surge In Orders</h2>On Jan. 7, One Stop Systems said that the company had received a pre-production order from a new U.S. defense prime contractor for the design, development, and delivery of ruggedized integrated compute, and visualization systems for U.S. Army combat vehicles."It also strengthens our position to compete for, and win, larger production opportunities as the Army pursues next-generation vision, sensor distribution and sensor processing technologies across its fleet of manned and unmanned platforms," <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://onestopsystems.com/blogs/press-releases/oss-announces-new-partnership-with-leading-u-s-defense-prime-to-develop-enhanced-integrated-vision-system-for-u-s-army">said</a> Mike Knowles, President and CEO of One Stop Systems.In December 2025, the company won a $1.2 million production order from Safran Federal Systems, which brought the aggregate order value to about $1.9 million with the company following a September 2025 order, OSS said at the time.The company also sold all its assets and operations of Bressner Technology GmbH in December 2025 for $22.4 million. OSS had acquired Bressner in October 2018 for about $5.6 million.In its latest quarterly update, One Stop Systems posted revenues of $18.76, up about 37% from the $13.7 million in the same period last year. The company also posted earnings per share of $0.01 compared to a loss per share of $0.32 in the same period last year.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/OSS">OSS stock</a> was in ‘extremely bullish’ territory over the past day amid ‘extremely high’ message volumes.One bullish user noted the U.S. Army’s potential funding for a rugged 360-degree Situational Awareness system, anticipating that this could lead to over $200 million in orders for the company over the next three to five years.<stembedurl>https://stocktwits.com/DisneyTrader/message/641562227</stembedurl>&nbsp;Another user called OSS an ‘under the radar’ AI stock that has been left behind.<stembedurl>https://stocktwits.com/RetireQuick/message/641566304</stembedurl>&nbsp;A third user forecasted that the stock’s price could go to $20.<stembedurl>https://stocktwits.com/GoChiefs15/message/641571302</stembedurl>&nbsp;Shares of OSS have gained over 239% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

In this photo illustration, the One Stop Systems (OSS) logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

OSS Stock Rallied Over 50% In The Last 5 Days — Why Is Retail Still Bullish?

Retail optimism for One Stop Systems comes amid the company’s about $1.2 million pre-production order from a U.S. defense prime contractor announced last week.

<ul class="summary-bullets"><li>Friedland proposed an eight-point plan aimed at turning the company around, including immediate governance reforms and operational leadership changes.</li><li>His recommendations include reconstitution of the company’s board of directors and suspension of all cash board compensation until the stock value improves to $10 per share.&nbsp;</li><li>He further recommended forming an independent special committee to evaluate strategic alternatives, including sale, take-private transaction, or merger scenarios.</li></ul>&nbsp;Shares of Lulu's Fashion Lounge Holdings, Inc. (LVLU) jumped 123% on Monday after activist investor Friedland Enterprises acquired approximately 5% of the company’s common stock and called for governance reforms in the company.Friedland Enterprises founder Christian Friedland <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2026/01/12/3217092/0/en/Friedland-Enterprises-Discloses-5-Stake-in-Lulu-s-Fashion-Lounge-Holdings-Calls-for-Governance-Reforms-and-Strategic-Review.html">said</a> that LVLU shares are “significantly undervalued” despite the company achieving two consecutive quarters of positive adjusted core profit and expanding gross margins."Management has been working through an operational turnaround, achieving positive EBITDA, improved margins, and balance sheet improvements," said Friedland. "What remains is governance reform, transparency, and strategic direction."<h2 class="st-heading-2">Friedland’s Proposal</h2>Friedland proposed an eight-point plan aimed at turning the online retailer around, including immediate governance reforms and operational leadership changes. His recommendations include reconstitution of the company’s board of directors and suspension of all cash board compensation until stock value improves to $10 per share.He further recommended hiring a permanent chief financial officer (CFO) within 120 days, returning founder Colleen Winter to the board and forming an independent special committee to evaluate strategic alternatives including sale, take-private transaction, or merger scenarios."My intent is constructive engagement, not confrontation,” Friedland said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around LVLU rose from ‘neutral’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.A Stocktwits user voiced optimism for the stock hitting as high as $25.<stembedurl>https://www.stocktwits.com/flytomoonwee/message/641550673</stembedurl>Another user opined that the stock jump implies a “solid bounce off recent lows” that could signal a trend change.<stembedurl>https://www.stocktwits.com/topstockalerts/message/641534077</stembedurl><a href="https://stocktwits.com/symbol/LVLU">LVLU stock</a> has dropped 5% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/atra-stock-nearly-halves-in-value-after-fda-refuses-approval-for-immunotherapy/cmUaE0tR4Em">ATRA Stock Nearly Halves In Value After FDA Refuses Approval For Immunotherapy: Retail Sees ‘Big Fight Back’</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Lulu's Fashion Lounge logo is displayed on the screen of an iPad. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Why Did LVLU Stock More Than Double Today?

Activist investor Friedland Enterprises acquired approximately 5% of Lulu's Fashion Lounge’s common stock and also called for governance reforms in the company. 

<ul class="summary-bullets"><li>On Dec. 31, 2025, INBS stock closed over 132% after announcing a manufacturing partnership with Syrma Johari MedTech.</li><li>The company also announced a private placement with two healthcare-focused institutional investors to issue 2.3 million shares of common stock.</li><li>Intelligent Bio Solutions had announced a 1-for-10 reverse stock split effective Dec. 15.</li></ul>Shares of Intelligent Bio Solutions (INBS) have seen strong buying interest in recent weeks, with the stock adding more than 35% in premarket trading on Monday.&nbsp;From the close on Dec. 30, 2025, to Jan. 9, 2026, <a href="https://stocktwits.com/symbol/INBS">INBS stock</a> has surged about 337%, breaching both its 50-day moving average (50-DMA) and the longer-term 200-DMA during the rally.This stellar rally has made it a momentum favorite among retail traders, driven by a recent manufacturing partnership, fresh capital boost, and a compliance update with Nasdaq; however, concerns around dilution and its volatile ride continue to temper sentiment.&nbsp;<h2 class="st-heading-2">What Led To INBS Rally?</h2>On Dec. 31, 2025, INBS stock closed over 132% after announcing a manufacturing partnership with Syrma Johari MedTech to scale production of its fingerprint drug-screening reader. The deal is expected to cut annual production costs by over 40% and lift gross margins by about 20 percentage points, while expanding manufacturing capacity fourfold, Intelligent Bio Solutions said. The company said the deal positions it well for its U.S. market launch in 2026.The company also announced a private placement with two healthcare-focused institutional investors to issue 2.3 million shares of common stock along with Series K-1 and K-2 warrants for the same number of shares at $4.35 each, raising around $10 million before fees. The warrants have an exercise price of $4.10 per share.Separately, on January 7, Intelligent Bio Solutions was notified by Nasdaq that it had regained compliance to trade on the Nasdaq Capital Market. The closing bid price of INBS stock had remained at $1.00 or higher for 14 consecutive business days, from Dec. 16, 2025, to Jan. 6, 2026. The company had announced a 1-for-10 reverse stock split effective Dec. 15.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the bullish premarket movement, retail sentiment on Stocktwits remained in the ‘neutral’ zone over the past 24 hours. INBS was among the top-trending tickers on Stocktwits at the time of writing.One user thinks short interest is extremely high and predicts the stock could fall to $15. It is currently trading at $24.2.<stembedurl>https://stocktwits.com/Harsh1210/message/641505295</stembedurl>However, another user sees a setup that pits the company’s operational progress against short-term dilution fears.<stembedurl>https://stocktwits.com/Atdanaiw/message/641502687</stembedurl>Read also: <a href="https://stocktwits.com/news-articles/markets/equity/silver-gold-record-highs-analyst-michael-oliver-predicts-500-breakout/cmU9UNvR4Ec">Silver’s Next Move Could Be Explosive: Michael Oliver Sees $200–$500 Upside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

INBS Stock Has Surged Over 330% So Far In January – But Retail Traders Are Warning Of A Pullback 

INBS shares were up more than 35% in premarket trading on Monday and were among the top trending tickers on Stocktwits.

INBS Stock Gains Triple-Digit Rally So Far In January: What’s Driving The Surge And What Traders Are Saying

<ul class="summary-bullets"><li>The company is also in focus as market interest grows in infrastructure and energy in 2026.&nbsp;</li><li>On January 6, Nuvve announced that its Japanese subsidiary had secured rights to install and operate a grid-scale battery energy storage system (BESS) in Oyada, Mino City, Gifu Prefecture.</li><li>Earlier, the company had told stockholders that it was increasing its business focus on stationary energy storage systems and microgrids to capitalize on energy markets.</li></ul>Nuvve Holding Corp. (NVVE) garnered significant attention among investors on Wednesday as stock surged over 70% in the morning’s trade.The rally comes amid growing market interest in infrastructure and energy as well as the company’s recent announcement of a battery energy storage system in Japan.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around NVVE stock jumped to ‘extremely bullish’ from ‘bearish’ territory over 24 hours. Meanwhile, message volume for the stock shifted to ‘extremely high’ from ‘low’ levels in the same period.One bullish user noted how the company’s Japan launch news from Tuesday went unnoticed, noting it was good for the company. The user also highlighted the positive impact of their EV charging and energy spaces launch.<stembedurl>https://stocktwits.com/MS_Tammy/message/641068166</stembedurl>&nbsp;Another bullish user noted how EV and charging infrastructure would be one of the dominant themes in 2026.<stembedurl>https://stocktwits.com/unton/message/641076611</stembedurl><h2 class="st-heading-2">Pivot To Energy Storage</h2>On January 6, Nuvve announced that its Japanese subsidiary had secured rights to install and operate a grid-scale battery energy storage system (BESS) in Oyada, Mino City, Gifu Prefecture in the country with an output of two megawatts (MW) and a storage capacity of 8MWh. The site is scheduled to begin operations in November 2026.Following this, Nuvve Japan's total contract capacity is now at 6MW. Gregory Poilasne, CEO of Nuvve, said that the deal combined with the company’s European battery projects, would create a strong and growing revenue stream into late 2026 and early 2027.As markets head into 2026, investors are eyeing capital inflows into infrastructure, energy, and other undervalued sectors. According to a <a href="https://stocktwits.com/discussions/which-theme-will-matter-most-for-portfolios-in-2026/640814162">Stocktwits poll</a> in partnership with Polymarket that sought to measure the industries that would matter in 2026, 39% of users voted for physical AI infrastructure while 36% picked Power &amp; Energy. Meanwhile, 14% of users voted for Healthcare Value &amp; Innovation.In December 2025, the vehicle-to-grid (V2G) technology company told stockholders in a letter that it was increasing its business focus on stationary energy storage systems and microgrids to capitalize on energy markets.<a href="https://stocktwits.com/symbol/NVVE">Shares of NVVE</a> lost over 97% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

A staff member lifts all vanadium flow energy storage battery accessories at an energy storage battery production line

Nuvve Stock In Focus As It Soars Over 78% — What Are Retail Investors Saying?

Nuvve Holding is gaining retail attention over the company’s recent announcement of a battery energy storage system in Japan. 

<ul class="summary-bullets"><li>The deal is expected to close in the first quarter of 2026. Mobileye said that strong traction in advanced vehicle autonomy and core</li><li>ADAS technology has created a current automotive revenue pipeline of $24.5 billion over the next eight years for the company.</li><li>Speaking at the Consumer Electronics Show (CES) 2026, the company’s CEO said it is competing on 100 million more Request for Quotation (RFQ) for chips, further increasing the pipeline.</li></ul>Shares of Mobileye Global Inc. (MBLY) surged over 10% in Tuesday’s after-market trading as the company announced plans to acquire Israeli startup Mentee Robotics for $900 million in a push into the humanoid robots market.The self-driving car systems firm will pay $612 million in cash and the rest in up to 26.2 million shares of Mobileye Class A common stock for the startup, <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.mobileye.com/news/mobileye-to-acquire-mentee-robotics-to-accelerate-physical-ai-leadership/">according</a> to the company. The deal is expected to close in the first quarter of 2026.<h2 class="st-heading-2">Deal Contours</h2>This deal will combine Mobileye’s advanced AI technology and global production expertise with Mentee’s humanoid platform and AI capabilities that will result in a company that combines autonomous driving and humanoid robotics.Mobileye’s acquisition of Mentee comes even as other automakers make a strong push into humanoid robots. The deal is likely to put Mobileye in competition with <a href="https://stocktwits.com/symbol/TSLA">Tesla</a> Inc.’s (TSLA) Optimus.Mobileye said that strong traction in advanced vehicle autonomy and core ADAS technology has created a current automotive revenue pipeline of $24.5 billion over the next eight years for the company, up more than 40 percent compared to January 2023, the company said.The acquisition broadens the scope of the company’s business with a decisive step toward physical artificial intelligence with intelligence systems that will be able to understand context, intent, and interact with humans while acting safely.Mentee’s acquisition will accelerate its go-to-market strategy, with first on-site proof-of-concept deployments with customers expected in 2026, the company said. The deployments are expected to operate autonomously, and the company is targeting series production and commercialization in 2028.“Today marks a new chapter for robotics and automotive AI, and the beginning of Mobileye 3.0,” said Amnon Shashua, President and CEO of Mobileye. “By combining Mentee’s breakthroughs in humanoid robotics with Mobileye’s expertise in automotive autonomy, and its proven ability to productize advanced AI, we have a unique opportunity to lead the evolution of physical AI across robotics and autonomous vehicles on a global scale.”Mentee will operate as an independent unit within Mobileye for the foreseeable future and will gain access to Mobileye’s customer base as part of the deal.<h2 class="st-heading-2">Forward Guidance</h2>Speaking at the Consumer Electronics Show (CES) 2026, Shashua reiterated the forward guidance of a $24.5 billion projected revenue pipeline by 2033 based on signed contracts. This includes $18 billion in revenues awarded over the past three years.Shashua also said the company is competing on 100 million more Request for Quotation (RFQ) for chips, further increasing the pipeline.Since its inception, Mobileye’s chips have been deployed in over 230 million cars, Shashua said, estimating that this could be about one eighth of the total cars on the planet.The company receives data from over 8 million cars everyday to support its technology that builds high-definition maps and has harvested data over 32 billion miles. Three new OEMs have also joined the company in 2025, the company said.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around MBLY stock trended in the ‘extremely bullish’ territory over the past day amid ‘extremely high’ message volume.One Stocktwits user opined that Mentee Robotics are quite capable compared to Tesla.&nbsp; <stembedurl>https://stocktwits.com/AlphaBull_10M/message/641016597</stembedurl>&nbsp;Another user called this a turn around play.<stembedurl>https://stocktwits.com/TheBullishTrade/message/641019239</stembedurl>&nbsp;<a href="https://stocktwits.com/symbol/MBLY">Shares of MBLY</a> were among the top trending tickers on Stocktwits at the time of writing. The stock has lost over 44% of its value in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also Read: <a href="https://stocktwits.com/news-articles/markets/equity/musk-xai-raises-20-billion-dollars-in-series-e-funding-round/cmxD4CPR4cT">Elon Musk’s xAI Raises $20B In Series E Funding Round, Exceeds Its Own Target</a> &nbsp;

In this photo illustration, a person holds a smartphone displaying the logo of Mobileye Global Inc.

Mobileye Global Shares Rally On $900M Mentee Robotics Deal

Mobileye will pay $612 million in cash and the rest in Class A common shares for humanoid robots the company. 

<ul class="summary-bullets"><li>Sidus Space has been named as one of the awardees for the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) contract, part of the larger Golden Dome mission, with a $151 billion contract ceiling.&nbsp;</li><li>The company has also been expanding beyond space satellites to end-to-end space manufacturing, AI-driven data solutions, and space and defense hardware.&nbsp;</li><li>Shares of SIDU were up over 19% on Friday morning.</li></ul>Shares of Sidus Space Inc. (SIDU) have gained over 390% in the past month, making the space stock one of the most noticeable movers in the market. Despite the massive rally, retail investors remain bullish on the stock.Some investors expect the shares to cross the $4 mark in Friday’s trade, while others are gunning for SIDU shares to surge to as high as $10 in the long term. The stock is already up over 19% in Friday’s premarket trade, hovering around the $3.72 mark at the time of writing.Retail traders are optimistic that Sidus Space will benefit from the overall rally in space stocks in 2025, partly due to chatter about SpaceX’s public offering, and further buoyed by the Trump administration’s expansive space policy. In addition, the company won a large contract from the Missile Defense Agency (MDA) and announced the pricing of a public offering of 19 million shares.<h2 class="st-heading-2">What Are Stocktwits Users Saying?</h2>On Stocktwits, retail sentiment around Sidus Space stock has remained in the ‘extremely bullish’ territory over the past month amid ‘extremely high’ message volumes.<figure class="image"><img style="aspect-ratio:1277/152;" src="https://news.stocktwits-cdn.com/Screenshot_2026_01_02_at_7_42_01_PM_png_6c788ecd29.webp" alt="On Stocktwits, retail sentiment around Sidus Space stock has remained in the ‘extremely bullish’ territory over the past month amid ‘extremely high’ message volumes." width="1277" height="152"></figure>One user noted the Sidus Space’s shift from commercial to government contracts, while also highlighting the upcoming SpaceX initial public offering and AI data center boom as positives for the company.<stembedurl>https://stocktwits.com/Rod92/message/640607721</stembedurl>&nbsp;Another user noted that the stock could still be in price-discovery mode.<stembedurl>https://stocktwits.com/jordonwillusu/message/640619714</stembedurl>&nbsp;One bullish user noted that while the stock may not be risk-free, its momentum was worth noting.<stembedurl>https://stocktwits.com/maynotcung/message/640620048</stembedurl>&nbsp;<h2 class="st-heading-2">Long-Term Value</h2>Earlier in December, Sidus Space announced its selection as one of the awardees for the Missile Defense Agency’s Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) contract with a $151 billion ceiling. This deal, part of the broader Golden Dome missile defense strategy in the U.S., makes Sidus eligible to compete for future task orders. Shortly after, the space company announced a public offering that raised approximately $25 million.In the past year, Sidus has also been <a href="https://stocktwits.com/news-articles/markets/equity/sidus-space-liftoff-a-tiny-defense-win-sparked-a-massive-rally/cL74x4eREUX">expanding</a> its footprint beyond space satellites, building up for end-to-end space manufacturing, AI-driven data solutions, and space and defense hardware.The company has also enjoyed a leg up amid the broader move in the space sector, amid SpaceX’s massive IPO chatter and the White House’s push for more lunar exploration, commercial launch services, and sustainable, cost-effective space missions.<a href="https://stocktwits.com/symbol/SIDU">Shares of SIDU</a> have gained nearly 3% in the past year.For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

In this photo illustration, the Sidus Space logo is seen displayed on a smartphone screen.

SIDU Stock Is Already Up 390% In The Last Month – Why Is Retail Still Bullish?

Sidus Space is enjoying its moment in the spotlight after winning a massive defense contract, and the growth witnessed by the space sector in recent months.

Vanguard Group, Inc. - Vanguard Extended Market Index ETF

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

VXF
Vanguard Extended Market ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest VXF News

VXFVanguard Extended Market ETF